Literature DB >> 24361573

In vitro metabolism of rebaudioside B, D, and M under anaerobic conditions: comparison with rebaudioside A.

Sidd Purkayastha1, George Pugh2, Barry Lynch3, Ashley Roberts4, David Kwok5, Stanley M Tarka6.   

Abstract

The hydrolysis of the steviol glycosides rebaudioside A, B, D, and M, as well as of steviolbioside (a metabolic intermediate) to steviol was evaluated in vitro using human fecal homogenates from healthy donors under anaerobic conditions. Incubation of each of the rebaudiosides resulted in rapid hydrolysis to steviol. Metabolism was complete within 24h, with the majority occurring within the first 8h. There were no clear differences in the rate or extent of metabolism of rebaudioside B, D, or M, relative to the comparative control rebaudioside A. The hydrolysis of samples containing 2.0mg/mL of each rebaudioside tended to take slightly longer than solutions containing 0.2mg/mL. There was no apparent gender differences in the amount of metabolism of any of the rebaudiosides, regardless of the concentrations tested. An intermediate in the hydrolysis of rebaudioside M to steviol, steviolbioside, was also found to be rapidly degraded to steviol. The results demonstrate that rebaudiosides B, D, and M are metabolized to steviol in the same manner as rebaudioside A. These data support the use of toxicology data available on steviol, and on steviol glycosides metabolized to steviol (i.e., rebaudioside A) to substantiate the safety of rebaudiosides B, D, and M.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaerobic; Human; In vitro metabolism; Rebaudiosides; Steviol; Steviolbioside

Mesh:

Substances:

Year:  2013        PMID: 24361573     DOI: 10.1016/j.yrtph.2013.12.004

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  6 in total

1.  Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract.

Authors:  Maged Younes; Gabriele Aquilina; Karl-Heinz Engel; Paul J Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Rainer Gürtler; Ursula Gundert-Remy; Trine Husøy; Melania Manco; Wim Mennes; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Matthew Wright; José Manuel Barat Baviera; Gisela Degen; Lieve Herman; Jean-Charles Leblanc; Detlef Wölfle; Jaime Aguilera; Alessandra Giarola; Camilla Smeraldi; Giorgia Vianello; Laurence Castle
Journal:  EFSA J       Date:  2022-05-16

2.  The natural sweetener metabolite steviol inhibits the proliferation of human osteosarcoma U2OS cell line.

Authors:  Jun-Ming Chen; Jue Zhang; Yong-Mei Xia; Xiao-Xia Wang; Jian Li
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

3.  Microbial production of next-generation stevia sweeteners.

Authors:  Kim Olsson; Simon Carlsen; Angelika Semmler; Ernesto Simón; Michael Dalgaard Mikkelsen; Birger Lindberg Møller
Journal:  Microb Cell Fact       Date:  2016-12-07       Impact factor: 5.328

Review 4.  Development of Next Generation Stevia Sweetener: Rebaudioside M.

Authors:  Indra Prakash; Avetik Markosyan; Cynthia Bunders
Journal:  Foods       Date:  2014-02-27

Review 5.  The Impact of Artificial Sweeteners on Body Weight Control and Glucose Homeostasis.

Authors:  Michelle D Pang; Gijs H Goossens; Ellen E Blaak
Journal:  Front Nutr       Date:  2021-01-07

6.  Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively.

Authors:  Junming Chen; Yongmei Xia; Xiaochen Sui; Qingrui Peng; Tongtong Zhang; Jian Li; Jue Zhang
Journal:  Oncotarget       Date:  2018-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.